Table 1. Transaminase level at baseline and during intravenous immunoglobulin infusion.
GBS, Guillain-Barré syndrome; AMAN, acute motor axonal neuropathy; AIDP, acute inflammatory demyelinating polyneuropathy; AMSAN, acute motor sensory axonal neuropathy; U/L, units per liter; AST, aspartate transaminase; ALT, alanine transaminase.
| Serial Number | Age (Years) | Sex | Name of Autoimmune Disorder | AST Level (U/L) Baseline | AST Level (U/L) During Treatment | ALT Level (U/L) Baseline | ALT Level (U/L) During Treatment |
| 1 | 16 | Male | GBS (AMSAN) | 20 | 40.25 | 88 | 92.5 |
| 2 | 17 | Male | GBS (AMSAN) | 47 | 31 | 35 | 29 |
| 3 | 25 | Female | GBS (AMAN) | 24 | 138.25 | 31 | 155.16 |
| 4 | 26 | Female | GBS (AIDP) | 36 | 130 | 24 | 244 |
| 5 | 31 | Male | GBS (AIDP) | 30 | 168.66 | 45 | 200.16 |
| 6 | 35 | Male | GBS (AIDP) | 37 | 144.66 | 40 | 278 |
| 7 | 45 | Female | GBS (AMSAN) | 30 | 222 | 32 | 169 |
| 8 | 50 | Male | GBS (AIDP) | 29 | 57 | 38 | 138 |
| 9 | 56 | Female | GBS (AIDP) | 21 | 54.5 | 23 | 35.0 |
| 10 | 57 | Female | GBS (AMAN) | 20 | 149.25 | 31 | 159.55 |
| 11 | 45 | Male | Myasthenic crisis | 36 | 53 | 40 | 179 |